This September, Jones Radiology is proud to again support The Hospital Research Foundation Group (THRFG), donating $10 for every prostate MRI and PSMA PET scan performed to Australian Prostate Cancer, helping raise awareness and support research into prostate cancer.
September is Prostate Cancer Awareness Month – an opportunity to start conversations about prostate health, understand individual risk and shine a light on the research helping improve the detection, treatment and management of prostate cancer.
Prostate cancer is the most commonly diagnosed cancer in Australian men. While the risk increases with age, family history can also play an important role. Early prostate cancer often causes no symptoms, making conversations about prostate health particularly important.
Know your risk
There is currently no national population screening program for prostate cancer in Australia.
For men considering prostate cancer testing, a GP can discuss individual circumstances, including age, family history, symptoms and the potential benefits and limitations of PSA testing.
A PSA blood test measures the level of prostate-specific antigen in the blood. An elevated PSA does not necessarily mean prostate cancer is present, as PSA can also be raised by non-cancerous conditions. If a PSA result or other assessment raises concerns, further investigation may be recommended.
If you are concerned about your prostate health or have a family history of prostate cancer, speak with your GP about what is appropriate for you.
Where does imaging fit in?
When further investigation is required, medical imaging can provide important information to help doctors understand what is happening within and around the prostate.
Prostate MRI
A specialised multiparametric MRI can provide detailed images of the prostate and may be recommended when prostate cancer is suspected.
Prostate MRI can help identify areas that may require further investigation, assist doctors in determining whether a biopsy is needed and provide information about the extent of disease.
PSMA PET
For some men with prostate cancer, PSMA PET can provide information beyond the prostate itself.
PSMA PET uses a specialised tracer that targets prostate-specific membrane antigen, which is commonly found on prostate cancer cells. The scan is performed alongside CT imaging to help locate prostate cancer lesions.
PSMA PET has an established role in the initial staging of certain intermediate- to high-risk prostate cancers and in investigating recurrence following treatment.
Supporting research that could change the future
At Jones Radiology, our commitment to prostate cancer awareness extends beyond imaging.
We are proud to support The Hospital Research Foundation Group charity, Australian Prostate Cancer, a charity dedicated to funding research into the detection and treatment of prostate cancer and preventing the metastatic spread of the disease.
Throughout September, Jones Radiology will donate $10 for every prostate MRI and PSMA PET scan performed to Australian Prostate Cancer, supporting ongoing research into prostate cancer detection, treatment and care.
Our longstanding partnership with The Hospital Research Foundation Group (THRFG) reflects our commitment to supporting research that can help improve outcomes for people affected by prostate cancer.
Read more about this research through Australian Prostate Cancer →
A clearer picture today. A stronger future tomorrow.
From understanding individual risk and investigating a raised PSA, through to diagnosis, staging and monitoring, imaging can play an important role in the prostate cancer journey.
But progress doesn’t stop at diagnosis.
By supporting research, we can help advance the way prostate cancer is detected, understood and treated in the future.
If you have concerns about your prostate health, speak with your GP or healthcare professional about the right next step for you.
Learn more about Prostate MRI →
This information is intended as general information only and does not replace medical advice. If you have concerns about your prostate health, please speak with your GP or treating healthcare professional.
